Page-1
VICC PHI 1044 A Phase 1 Dose Escalation Safety and... VICC HEM 1239 Phase I Study of Bortezomib and Romidepsin in... VICC HEM 1239 Phase I Study of Bortezomib and Romidepsin in... VICC HEM 1239 Phase I Study of Bortezomib and Romidepsin in... VICC BRE 0889 A Multicenter Study in Patients Undergo ing... VICC BRE 0889 A Multicenter Study in Patients Undergo ing... VICC HEM 1146 Ofatumu mab in combina tion with high dose... VICC PHI 1044 A Phase 1 Dose Escalation Safety and... VICC HEM 1105 A Phase 2/3 Multicenter, Randomized, Open-Label... ECOG HEM E2408 A 3-Arm Randomized Phase II Trial of... VICC DERM 1059 Phase IV Randomized Study of Two Dose Levels of... VICC HEM 0835 A Phase II Randomized Study of Lenalidomide or... Click here to print
this page (PDF) Hematology/Oncology Flowcharts